AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,850
+150 (0.85%)
Last updated: Jun 25, 2025
-7.47%
Market Cap 402.12B
Revenue 29.69B
Net Income 22.63B
Shares Out 22.53M
EPS 1,022.72
PE Ratio 17.77
Forward PE 47.86
Dividend n/a
Ex-Dividend Date n/a
Volume 135,359
Average Volume 212,791
Open 17,860
Previous Close 17,700
Day's Range 17,510 - 18,120
52-Week Range 11,980 - 25,900
Beta 1.60
RSI 46.70
Earnings Date n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

News

There is no news available yet.